Geode Capital Management
FTH

Geode Capital Management’s Faeth Therapeutics FTH Stock Holding History

Geode Capital Management’s Portfolio FTH Stock Details FTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$365K Buy
14,616
+5,115
+54% +$118K ﹤0.01% 3713
2026
Q1 		$300K Buy
+9,501
New +$190K ﹤0.01% 3780
2025
Q2 		– Sell
-7,535
Closed -$59.4K – 4514
2025
Q1 		$59.4K Buy
7,535
+91
+1% +$865 ﹤0.01% 4162
2024
Q4 		$73K Sell
7,444
-713
-9% -$7.15K ﹤0.01% 4171
2024
Q3 		$97.6K Hold
8,157
– – ﹤0.01% 4109
2024
Q2 		$101K Buy
8,157
+1,341
+20% +$27.9K ﹤0.01% 4140
2024
Q1 		$143K Hold
6,816
– – ﹤0.01% 4040
2023
Q4 		$94.3K Hold
6,816
– – ﹤0.01% 4202
2023
Q3 		$102K Buy
6,816
+1,916
+39% +$41.2K ﹤0.01% 4242
2023
Q2 		$112K Hold
4,900
– – ﹤0.01% 4293
2023
Q1 		$147K Hold
4,900
– – ﹤0.01% 4179
2022
Q4 		$146K Buy
4,900
+305
+7% +$8.97K ﹤0.01% 4246
2022
Q3 		$142K Hold
4,595
– – ﹤0.01% 4387
2022
Q2 		$208K Sell
4,595
-8,196
-64% -$307K ﹤0.01% 4236
2022
Q1 		$590K Sell
12,791
-35
-0.3% -$2.79K ﹤0.01% 3860
2021
Q4 		$1.49M Sell
12,826
-873
-6% -$130K ﹤0.01% 3527
2021
Q3 		$2.88M Buy
13,699
+6,609
+93% +$1.2M ﹤0.01% 3201
2021
Q2 		$1.38M Buy
7,090
+1,220
+21% +$301K ﹤0.01% 3440
2021
Q1 		$1.71M Buy
+5,870
New +$1.96M ﹤0.01% 3334

Other funds holding FTH

SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
CP
Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return
BGI
B Group Inc Dallas, Texas $213M AUM 96.05% 1-Year Est. Return

Geode Capital Management's FTH Position: Q2 2026 in Review

Geode Capital Management increased its Faeth Therapeutics (FTH) stake by 54% in Q2 2026, buying an estimated $118K and bringing the position to 14,616 shares worth $365K. The position accounts for ﹤0.01% of the portfolio, ranked #3713.

Geode Capital Management first reported a position in FTH in Q1 2021 and has held it in 19 quarters since. The position peaked at $2.88M in Q3 2021. 45 funds tracked by Wall St. Rank hold FTH as of Q2 2026.

  • Geode Capital Management held 14,616 shares of Faeth Therapeutics worth $365K as of Q2 2026.
  • Geode Capital Management bought 5,115 Faeth Therapeutics shares in Q2 2026, an estimated $118K.
  • Faeth Therapeutics made up ﹤0.01% of Geode Capital Management's portfolio in Q2 2026, its #3713 holding.
  • Geode Capital Management first reported a position in Faeth Therapeutics in Q1 2021 and has held it in 19 quarters since.
  • Geode Capital Management's Faeth Therapeutics position peaked at $2.88M in Q3 2021.
  • 45 funds tracked by Wall St. Rank held Faeth Therapeutics as of Q2 2026.

Based on Geode Capital Management's 13F filing for Q2 2026, filed 12 Aug 2026.